✦ LIBER ✦

Ruboxistaurin: PKC-β inhibition for complications of diabetes

✍ Scribed by Danis, Ronald P; Sheetz, Matthew J

Book ID: 118178291
Publisher: Informa plc
Year: 2009
Tongue: English
Weight: 735 KB
Volume: 10
Category: Article
ISSN: 1465-6566
DOI: 10.1517/14656560903401620

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PKC inhibition and diabetic microvascula

PKC inhibition and diabetic microvascular complications

✍ Margaret Clarke; Paul M. Dodson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 524 KB

PKC-ɛ inhibition: a new therapeutic appr

PKC-ɛ inhibition: a new therapeutic approach for diabetic complications?

✍ A Avignon; A Sultan 📂 Article 📅 2006 🏛 Masson Editeur 🌐 French ⚖ 124 KB

Inhibition of PKC β by Ruboxistaurin Doe

Inhibition of PKC β by Ruboxistaurin Does Not Enhance the Acute Blood Pressure Response to Nitroglycerin

✍ Benson, C; Seger, M; Voelker, J 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Ruboxistaurin, a PKCβ inhibitor, inhibit

Ruboxistaurin, a PKCβ inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt

✍ Shinsuke Nakamura; Yuichi Chikaraishi; Kazuhiro Tsuruma; Masamitsu Shimazawa; Hi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 922 KB

In silico design of peptidomimetics for

In silico design of peptidomimetics for PKC-β II inhibition: perspectives for diabetic cardiomyopathy therapy

✍ Rohit, Shishir; Balupuri, Anand; Sobhia, M. Elizabeth 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 573 KB

Curcumin attenuates diabetic nephropathy

Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats

✍ Vivian Soetikno; Kenichi Watanabe; Flori R. Sari; Meilei Harima; Rajarajan A. Th 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

## Abstract **Scope**: We hypothesized that curcumin, a potent anti‐oxidant, might be beneficial in ameliorating the development of diabetic nephropathy through inhibition of PKC‐α and PKC‐β1 activity‐ERK1/2 pathway. **Methods and results**: Diabetes was induced by a single intraperitoneal injecti